1. Home
  2. NAMS vs LU Comparison

NAMS vs LU Comparison

Compare NAMS & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • LU
  • Stock Information
  • Founded
  • NAMS 2019
  • LU 2005
  • Country
  • NAMS Netherlands
  • LU China
  • Employees
  • NAMS N/A
  • LU N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • LU Finance: Consumer Services
  • Sector
  • NAMS Health Care
  • LU Finance
  • Exchange
  • NAMS Nasdaq
  • LU Nasdaq
  • Market Cap
  • NAMS 3.1B
  • LU 3.1B
  • IPO Year
  • NAMS N/A
  • LU 2020
  • Fundamental
  • Price
  • NAMS $32.86
  • LU $4.01
  • Analyst Decision
  • NAMS Strong Buy
  • LU Hold
  • Analyst Count
  • NAMS 9
  • LU 1
  • Target Price
  • NAMS $41.89
  • LU $3.20
  • AVG Volume (30 Days)
  • NAMS 974.1K
  • LU 3.3M
  • Earning Date
  • NAMS 11-05-2025
  • LU 10-21-2025
  • Dividend Yield
  • NAMS N/A
  • LU N/A
  • EPS Growth
  • NAMS N/A
  • LU N/A
  • EPS
  • NAMS N/A
  • LU N/A
  • Revenue
  • NAMS $64,006,000.00
  • LU $4,671,260,668.00
  • Revenue This Year
  • NAMS N/A
  • LU N/A
  • Revenue Next Year
  • NAMS $1.67
  • LU N/A
  • P/E Ratio
  • NAMS N/A
  • LU N/A
  • Revenue Growth
  • NAMS 762.15
  • LU N/A
  • 52 Week Low
  • NAMS $14.06
  • LU $2.22
  • 52 Week High
  • NAMS $34.62
  • LU $4.57
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 72.18
  • LU 65.11
  • Support Level
  • NAMS $27.15
  • LU $3.75
  • Resistance Level
  • NAMS $34.59
  • LU $4.57
  • Average True Range (ATR)
  • NAMS 1.47
  • LU 0.26
  • MACD
  • NAMS 0.50
  • LU 0.03
  • Stochastic Oscillator
  • NAMS 73.37
  • LU 64.34

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About LU Lufax Holding Ltd each representing two (2)

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

Share on Social Networks: